Many life sciences companies have experienced a period of growth over the last few years and have been able to expand their offerings. However the life sciences sector has long been a core focus for the European Commission and national competition authorities alike, and therefore companies must successfully manage competition risk when developing their business. Life sciences companies must tread especially carefully when promoting their products and developing pricing strategies.

Oradores:: Natasha Tardif

Tipo de evento: Seminario web, Educación legal continua/desarrollo profesional continuo

Fecha/hora de inicio:
6 October 2021, 12:00 PM France Daylight Time
Fecha/hora de finalización:
6 October 2021, 1:00 PM France Daylight Time

Preparation is key and during this webinar Natasha Tardif will be covering the key competition issues that life sciences companies should be aware of in Europe: pay-for-delay-practices, generics exclusion and price gouging. Natasha will outline the pitfalls and provide practical suggestions, she will also be available for Q&A.

11:00 GMT / 10:00 BST/ 9:00 CET

PLEASE READ – Important CLE information:

This program is presumptively approved for 1.0 CLE credit in California, Connecticut, Illinois, New Jersey, New York, Pennsylvania, Texas and West Virginia. Applications for CLE credit will be filed in Delaware, Florida, Ohio, and Virginia. Attendees who are licensed in other jurisdictions will receive a uniform certificate of attendance but Reed Smith only provides credit for the states listed. Please allow four to six weeks after the program to receive a certificate of attendance.